Innoforce grabs $156.6m Series A

Innoforce, a Chinese biopharmaceutical manufacturing and development company, has closed $156.6 million in Series A financing.

Innoforce, a Chinese biopharmaceutical manufacturing and development company, has closed $156.6 million in Series A financing. Yanchuang Capital and South China Venture Capital led the round.

Source: Press Release